Wellcebro 200 Capsule contains Acebrophylline 200 mg, a bronchodilator and mucolytic agent used primarily in the management of respiratory conditions characterized by bronchospasm and excessive mucus production. Acebrophylline acts by relaxing the smooth muscles of the airways, thereby facilitating easier breathing, and by reducing the viscosity of bronchial secretions, which enhances mucus clearance. This dual action makes Wellcebro 200 effective in treating chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other obstructive airway diseases. The medication is indicated for patients experiencing wheezing, shortness of breath, and persistent cough associated with thick mucus. Wellcebro 200 Capsule should be administered as prescribed by a healthcare professional, typically taken orally with water, and dosage adjustments may be necessary based on the severity of the condition and patient response. Common side effects may include gastrointestinal discomfort, headache, or mild dizziness, though it is generally well tolerated. Caution is advised in patients with known hypersensitivity to methylxanthines or those with cardiac arrhythmias. Wellcebro 200 Capsule should be stored in a cool, dry place away from direct sunlight and out of reach of children. Always consult a physician before initiating therapy to ensure appropriate use and monitoring.